CD4 and Alzheimer disease: While the percentage of CD25+FOXP3+ gated cells among the total CD45+CD4+ in the 3xTg-AD brain were augmented, a significant reduction of the same cells was observed following treatment with anti-TNFSF10 (Fig. 4 panel b, Supplementary Fig. 3b).